CNXU (Conexeu Sciences) PEG Ratio: N/A (As of Aug. 10, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CNXU Conexeu Sciences Inc CNXU
12 GF Score
Price $7.08
! 1 Warning Sign
View Full Analysis

What is Conexeu Sciences PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Conexeu Sciences's PE Ratio without NRI is 0.00. Conexeu Sciences's 5-Year EBITDA growth rate is 0.00%. Therefore, Conexeu Sciences's PEG Ratio for today is N/A.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Conexeu Sciences's PEG Ratio or its related term are showing as below:



CNXU's PEG Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 1.96
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.

Conexeu Sciences  (NAS:CNXU) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.

Conexeu Sciences PEG Ratio Related Terms

Conexeu Sciences PEG Ratio Historical Data

* Premium members only.

The historical data trend for Conexeu Sciences's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Conexeu Sciences PEG Ratio Chart

Conexeu Sciences Annual Data
Trend Oct24 Oct25
PEG Ratio
0.00 0.00

Conexeu Sciences Quarterly Data
Oct24 Jan25 Apr25 Oct25 Jan26 Apr26
PEG Ratio Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

CNXU vs GALT, SRZN, RNAC: PEG Ratio Comparison

For the Biotechnology subindustry, Conexeu Sciences's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Conexeu Sciences PEG Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Conexeu Sciences's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Conexeu Sciences's PEG Ratio falls into.


CNXU
12GF Score
Conexeu Sciences Inc CNXU
PEG Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Conexeu Sciences PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Conexeu Sciences's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=/0.00
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.

Conexeu Sciences Business Description

Address 50 West Liberty Street, Suite 880, Reno, NV, USA, 89501
Conexeu Sciences Inc is an early-stage medical technology company. The company develops and supplies collagen-based technologies that helps doctors and patients regenerate tissue naturally, safely, and effectively. The company is focused on developing regenerative biomaterials that address relative needs in wound care, dentistry, and aesthetics. The company seek to provide physicians with device-based solutions that improve healing, restore soft tissue, and enhance patient outcomes across multiple clinical settings. The company focuses durable, and growing addressable markets in regenerative aesthetics, wound care, 3D-printed tissue structures, veterinary wound repair, and dental soft-tissue regeneration.
12GF Score

Get the complete analysis for CNXU

PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.08
Price